| Market Capitalization (Millions $) |
15 |
| Shares
Outstanding (Millions) |
41 |
| Employees |
10 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-8 |
| Cash Flow (TTM) (Millions $) |
-6 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Anebulo Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of novel inhalation therapies for the treatment of severe respiratory diseases. They aim to provide innovative solutions for patients suffering from conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma.
The company utilizes advanced inhalation technologies to deliver their drug candidates directly to the lungs, maximizing the drug's effectiveness and reducing systemic side effects. They are committed to improving patient outcomes and quality of life by addressing the unmet needs in respiratory medicine.
Anebulo Pharmaceuticals Inc has a robust pipeline of promising drug candidates in various stages of development. They prioritize rigorous research and development practices, conducting clinical trials to demonstrate the safety and efficacy of their products. Additionally, the company collaborates with academic institutions and industry partners to leverage expertise and accelerate the development of their therapies.
Overall, Anebulo Pharmaceuticals Inc is dedicated to revolutionizing respiratory care by bringing innovative inhalation therapies to market and making a significant impact on the lives of patients with severe respiratory diseases.
Company Address: 1017 Ranch Road 620 South Lakeway 78734 TX
Company Phone Number: 598-0931 Stock Exchange / Ticker: NASDAQ ANEB
|
0.21%